Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 21780101)

1.

P-glycoprotein binds to ezrin at amino acid residues 149-242 in the FERM domain and plays a key role in the multidrug resistance of human osteosarcoma.

Brambilla D, Zamboni S, Federici C, Lugini L, Lozupone F, De Milito A, Cecchetti S, Cianfriglia M, Fais S.

Int J Cancer. 2012 Jun 15;130(12):2824-34. doi: 10.1002/ijc.26285. Epub 2011 Oct 20.

PMID:
21780101
2.

Expression of the multidrug transporter P-glycoprotein is inversely related to that of apoptosis-associated endogenous TRAIL.

Souza PS, Madigan JP, Gillet JP, Kapoor K, Ambudkar SV, Maia RC, Gottesman MM, Leung Fung K.

Exp Cell Res. 2015 Jun 19. pii: S0014-4827(15)30013-6. doi: 10.1016/j.yexcr.2015.06.005. [Epub ahead of print]

PMID:
26101157
3.

Slp2-a inactivates ezrin by recruiting protein phosphatase 1 to the plasma membrane.

Yasuda T, Homma Y, Fukuda M.

Biochem Biophys Res Commun. 2015 May 15;460(4):896-902. doi: 10.1016/j.bbrc.2015.03.099. Epub 2015 Mar 25.

PMID:
25817786
4.

Adenovirus-delivered PDCD5 counteracts adriamycin resistance of osteosarcoma cells through enhancing apoptosis and inhibiting Pgp.

Zhao H, Peng C, Ruan G, Zhou J, Li Y, Hai Y.

Int J Clin Exp Med. 2014 Dec 15;7(12):5429-36. eCollection 2014.

5.

Ezrin-related Phosphoinositide pathway modifies RhoA and Rac1 in human osteosarcoma cell lines.

Lo Vasco VR, Leopizzi M, Della Rocca C.

J Cell Commun Signal. 2015 Mar;9(1):55-62. doi: 10.1007/s12079-015-0265-y. Epub 2015 Jan 25.

6.

Ezrin interacts with the scaffold protein IQGAP1 and affects its cortical localization.

Nammalwar RC, Heil A, Gerke V.

Biochim Biophys Acta. 2014 Dec 30. pii: S0167-4889(14)00454-6. doi: 10.1016/j.bbamcr.2014.12.026. [Epub ahead of print]

PMID:
25554515
7.

STRIPAK components determine mode of cancer cell migration and metastasis.

Madsen CD, Hooper S, Tozluoglu M, Bruckbauer A, Fletcher G, Erler JT, Bates PA, Thompson B, Sahai E.

Nat Cell Biol. 2015 Jan;17(1):68-80. doi: 10.1038/ncb3083. Epub 2014 Dec 22.

PMID:
25531779
8.

Association between P-glycoprotein expression and response to chemotherapy in patients with osteosarcoma: a systematic and meta-analysis.

Zhao ZG, Ding F, Liu M, Ma DZ, Zheng CK, Kan WS.

J Cancer Res Ther. 2014 Nov;10 Suppl:C206-9. doi: 10.4103/0973-1482.145874.

9.
10.

Ezrin silencing remodulates the expression of Phosphoinositide-specific Phospholipase C enzymes in human osteosarcoma cell lines.

Lo Vasco VR, Leopizzi M, Puggioni C, Della Rocca C.

J Cell Commun Signal. 2014 Sep;8(3):219-29. doi: 10.1007/s12079-014-0235-9. Epub 2014 Jul 30.

11.

Direct interaction of 14-3-3ζ with ezrin promotes cell migration by regulating the formation of membrane ruffle.

Chen M, Liu T, Xu L, Gao X, Liu X, Wang C, He Q, Zhang G, Liu L.

J Mol Biol. 2014 Sep 9;426(18):3118-33. doi: 10.1016/j.jmb.2014.06.021. Epub 2014 Jul 11.

PMID:
25020230
12.

Role of ezrin in osteosarcoma metastasis.

Ren L, Khanna C.

Adv Exp Med Biol. 2014;804:181-201. doi: 10.1007/978-3-319-04843-7_10. Review.

PMID:
24924175
13.

Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925.

Yang X, Yang P, Shen J, Osaka E, Choy E, Cote G, Harmon D, Zhang Z, Mankin H, Hornicek FJ, Duan Z.

Br J Cancer. 2014 Jun 10;110(12):2896-904. doi: 10.1038/bjc.2014.254. Epub 2014 May 22.

14.

Ezrin promotes invasion and migration of the MG63 osteosarcoma cell.

Zhang J, Zuo J, Lei M, Wu S, Zang X, Zhang C.

Chin Med J (Engl). 2014;127(10):1954-9.

PMID:
24824262
15.

Osteosarcoma metastasis: prospective role of ezrin.

Zhang Y, Zhang L, Zhang G, Li S, Duan J, Cheng J, Ding G, Zhou C, Zhang J, Luo P, Cai D, Kuang L, Zhou Y, Tong L, Yu X, Zhang L, Xu L, Yu L, Shi X, Ke A.

Tumour Biol. 2014 Jun;35(6):5055-9. doi: 10.1007/s13277-014-1799-y. Epub 2014 Mar 9. Review.

PMID:
24609902
16.

Quantitative analysis of ezrin turnover dynamics in the actin cortex.

Fritzsche M, Thorogate R, Charras G.

Biophys J. 2014 Jan 21;106(2):343-53. doi: 10.1016/j.bpj.2013.11.4499.

17.

CD44: evidence for its role in osteosarcoma morbidity and mortality.

[No authors listed]

Bonekey Rep. 2013 Mar 13;2:317. doi: 10.1038/bonekey.2013.51. eCollection 2013. No abstract available.

18.

Comment on Lun et al. entitled "The prognostic value of elevated ezrin in patients with osteosarcoma".

Li Z, Li Y.

Tumour Biol. 2014 May;35(5):5051. doi: 10.1007/s13277-013-1586-1. Epub 2014 Jan 5. No abstract available.

PMID:
24390666
19.

Design, synthesis and biological evaluation of ezrin inhibitors targeting metastatic osteosarcoma.

Paige M, Kosturko G, Bulut G, Miessau M, Rahim S, Toretsky JA, Brown ML, Üren A.

Bioorg Med Chem. 2014 Jan 1;22(1):478-87. doi: 10.1016/j.bmc.2013.11.003. Epub 2013 Nov 14.

20.

Meta-analysis of associations of the ezrin gene with human osteosarcoma response to chemotherapy and prognosis.

Wang Z, He ML, Zhao JM, Qing HH, Wu Y.

Asian Pac J Cancer Prev. 2013;14(5):2753-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk